The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Watson Pharmaceuticals
Approval Status: Approved January 1998
Treatment for: anticonvulsant
General Information
Clonazepam has been approved as an anticonvulsant to be manufactured in 0.5mg, 1mg and 2mg tablets.
It is the generic equivalent of Roche Laboratories' Klonopin.